Back to today’s briefing

Story perspectives

Myriad Genetics Poised for Strong Earnings Tomorrow

2/23/2025

25 2

Summary

Story summary

Myriad Genetics is set to unveil its earnings tomorrow, following a strong performance last quarter that surpassed revenue expectations by 1.3%, totaling $213.3 million. Analysts forecast a 7.8% growth this quarter, anticipating $211.9 million. The company's stock has surged 10.7%, with analysts eyeing an average price target of $20.09.

1 of 1

Story summary

Myriad Genetics is set to unveil its earnings tomorrow, following a strong performance last quarter that surpassed revenue expectations by 1.3%, totaling $213.3 million. Analysts forecast a 7.8% growth this quarter, anticipating $211.9 million. The company's stock has surged 10.7%, with analysts eyeing an average price target of $20.09.